Drugs News and Research

RSS

New study upends conventional theories about fluid nature of cell membranes

If you want to understand how the cell membrane works, Adam Cohen says, look no further than your kitchen. Cohen, a Professor of Chemistry and Chemical Biology and of Physics, is the lead author of a new study that upends the conventional theories about the fluid nature of cell membranes and how they react to tension.

2 Nov 2018

New way of identifying potential cancer drugs could streamline development of therapies

A new way of identifying potential cancer drugs could streamline the development of therapies, following a discovery by scientists.

2 Nov 2018

Insilico Medicine to present latest advances in drug development at Supply Side West Conference

Insilico Medicine, a Rockville-based company developing the end-to-end drug discovery pipeline utilizing the next generation artificial intelligence, will present its latest advances in modern drug development at the Supply Side West Conference in Las Vegas, 8-9 of November.

2 Nov 2018

Addressing chronic diseases could save tens of billions of dollars in healthcare costs annually

As Americans head to the polls this coming Tuesday, a top issue for all voters is the rising cost of healthcare. A new report has found that addressing chronic diseases, and in particular diabetes, could save tens of billions of dollars in healthcare costs annually.

2 Nov 2018

Certain test strips used with home-use devices may provide inaccurate results, warns FDA

The U.S. Food and Drug Administration today is warning patients and doctors, who use at-home or in-the-office medical devices to monitor levels of the blood thinner, warfarin, that certain test strips used with the devices may provide inaccurate results and should not be relied upon to adjust the drug dosage.

2 Nov 2018

Drexel University-led project to study how California's's changing cannabis laws impact public health

A Drexel University-led research project aimed at studying the health and behavioral effects of medical marijuana use for young adults living in Los Angeles has been renewed for another five years.

2 Nov 2018

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

City of Hope, a world-renowned independent cancer research and treatment center, and its affiliate, Translational Genomics Research Institute (TGen), have announced a letter of intent to develop a state-of-the-art cell therapy manufacturing facility in the Phoenix Metropolitan Area, a move that would improve the speed at which stem cell research and cancer treatment is delivered.

2 Nov 2018

Researchers for first time view serotonin activating its receptor using high-powered microscopes

Serotonin receptors are common drug targets in the treatment of pain, gastrointestinal dysfunctions, and mood disorders yet little is known about their three-dimensional structure.

2 Nov 2018

Researchers find a class of drug that could be promising treatment for uveitis

Ocular inflammation uveitis is a serious disease that can destroy eye tissue and cause irreversible blindness.

2 Nov 2018

Antibiotic found in dirt can destroy mutant mycobacteria responsible for TB, study suggests

For decades, doctors have been using antibiotics to fight tuberculosis. And consistently, the microbe responsible for the disease, Mycobacterium tuberculosis, has been fighting back. When confronted with current drugs, such as the antibiotic rifamycin, the bacterium often mutates in ways that make it resistant to the treatment.

1 Nov 2018

Podcast: KHN’s ‘What the Health?’ Open enrollment and a midterm preview

Nov. 1 marks the start of Open Enrollment for people buying their own coverage for 2019 in most states. Despite the turmoil surrounding the Affordable Care Act, most consumers will have more choices and mostly flat — and in some cases lower — premiums.

1 Nov 2018

Drug combination not more effective in improving depression than single antidepressant

Psychiatrists and GPs increasingly combine mirtazapine with an SSRI (selective serotonin reuptake inhibitor) or SNRI (serotonin-noradenaline reuptake inhibitor) antidepressant for patients whose depression does not respond to a single antidepressant.

1 Nov 2018

UA professor wins NIH grant to advance research in preventing heart failure

A University of Arizona College of Medicine - Phoenix researcher has received a $393,493 grant from the National Institutes of Health to further her research in reducing the risk of heart failure in patients with high blood pressure.

1 Nov 2018

Integral Molecular wins NIH grant to initiate target discovery program for Alzheimer’s disease

Integral Molecular, the industry leader in membrane protein technologies, was awarded a Small Business Innovation Research grant from the NIH to initiate a target discovery program for Alzheimer's disease.

1 Nov 2018

MCG selected as designated laboratory for NCI-MATCH trial

The Georgia Esoteric and Molecular Laboratory at the Medical College of Georgia at Augusta University has been selected as a designated laboratory for the National Cancer Institute's Molecular Analysis for Therapy Choice, or MATCH trial, which is assessing the effectiveness of targeting cancer-causing gene changes rather than cancer type.

1 Nov 2018

Researchers discover new antibiotic compounds

Researchers have identified new compounds that can target bacterial infection, potentially providing an answer to antibiotic resistance.

1 Nov 2018

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

AstraZeneca will present 20 abstracts including a late-breaking oral presentation on the full results from the Phase III cardiovascular outcomes trial DECLARE -TIMI 58, the broadest SGLT2 inhibitor CVOT conducted to date, as well as new research from the Company's Cardiovascular, Renal & Metabolism therapy area at the American Heart Association Scientific Sessions, November 10-12, 2018, in Chicago, Illinois, USA.

1 Nov 2018

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Ark Biosciences, a biotech company developing proprietary therapeutics for viral infection and respiratory diseases, announced today the significant progress in its phase 2 proof-of-concept study of ziresovir in the treatment of hospitalized RSV infected infants.

1 Nov 2018

Observing functional changes of cells in blood vessels may help detect early signs of atherosclerosis

A study in mice has shown that it may be possible to detect the early signs of atherosclerosis, which leads to blocked arteries, by looking at how cells in our blood vessels change their function.

1 Nov 2018

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

PAREXEL International Corporation has announced a new China Advisory Service to help global biopharmaceutical companies participate in the growing, yet complex market opportunity within China.

From Parexel 1 Nov 2018

Drugs News and Research

New study upends conventional theories about fluid nature of cell membranes

New way of identifying potential cancer drugs could streamline development of therapies

Insilico Medicine to present latest advances in drug development at Supply Side West Conference

Addressing chronic diseases could save tens of billions of dollars in healthcare costs annually

Certain test strips used with home-use devices may provide inaccurate results, warns FDA

Drexel University-led project to study how California's's changing cannabis laws impact public health

TGen, City of Hope to develop cell therapy manufacturing facility in Phoenix

Researchers for first time view serotonin activating its receptor using high-powered microscopes

Researchers find a class of drug that could be promising treatment for uveitis

Antibiotic found in dirt can destroy mutant mycobacteria responsible for TB, study suggests

Podcast: KHN’s ‘What the Health?’ Open enrollment and a midterm preview

Drug combination not more effective in improving depression than single antidepressant

UA professor wins NIH grant to advance research in preventing heart failure

Integral Molecular wins NIH grant to initiate target discovery program for Alzheimer’s disease

MCG selected as designated laboratory for NCI-MATCH trial

Researchers discover new antibiotic compounds

AstraZeneca to present Phase III CVOT DECLARE-TIMI 58 results at AHA Scientific Sessions

Phase 2 study of ziresovir for treating hospitalized RSV infected infants achieves significant progress

Observing functional changes of cells in blood vessels may help detect early signs of atherosclerosis

PAREXEL launches new China Advisory Service to help global biopharmaceutical companies navigate market opportunity within China

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News